Summary
Latest filing:
Brian Foard is EVP, Specialty, Pharma, & ID of Merck & Co., Inc. (MRK). 1 SEC Form 4 filing on record, dated 7 May 2026.
Trading pattern
InsiderAlpha's records for Brian Foard go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Brian Foard files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jennifer Zachary - $25.20M in MRK purchases and sales in the last 12 months
- Richard R. Deluca - $11.29M in MRK purchases and sales in the last 12 months
- Chirfi Guindo - $8.15M in MRK purchases and sales in the last 12 months
- David Michael Williams - $8.13M in MRK purchases and sales in the last 12 months
- Robert M. Davis - $5.60M in MRK purchases and sales in the last 12 months
- Caroline Litchfield - $5.02M in MRK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Brian Foard?
Brian Foard is a corporate insider, tracked as EVP, Specialty, Pharma, & ID of Merck & Co., Inc. (MRK). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Brian Foard last file a Form 4?
The only primary Form 4 on record is dated 7 May 2026.